Abstract
213
Objectives The nondisplaceable binding potential (BPND) represents an index of receptor density (Bmax), in vivo ligand-receptor affinity (1/KD), and nonspecific receptor binding (fND). Although often used as a metric for measuring disease specific changes in Bmax, several studies using different PET radioligands have shown that there is often no correlation between Bmax and BPND. The goal of this work was to examine this relation using the 5-HT1A PET ligand [18F]mefway (MEF) and carefully designed experiments to measure Bmax and in vivo dissociation constant (KDapp).
Methods Three-injection experiments, including partial saturation injections of MEF, were designed for high precision measurement of KDapp (= koff/kon) and Bmax in the 5-HT1A receptor-rich area of the mesial temporal cortex (MTC). PET experiments were conducted in six (2m,4f) anesthetized rhesus monkeys using arterial sampling to generate the input function. The “hot-cold” model was used to derive estimates of Bmax and KDapp with uncertainties calculated using generated-noise simulations. BPND measurements were performed using the Logan DVR (BPND=DVR-1) from the first injection data (high specific activity MEF and 90 minute duration) using the cerebellum as a reference region, which has shown to exhibit no measurable specific binding of MEF. BPND was regressed with KDapp, Bmax, and Bmax/KDapp.
Results The fractional uncertainties in the parameter estimates were: 6% (4-8%) for Bmax and 6% (4-11%) for KDapp. The intersubject coefficient of variation (CV=sd/mean) was 22%, 27%, and 21% (BPND,KDapp,Bmax). Regression analysis showed no significant correlation between BPND and Bmax (p=0.26) or KDapp (p=0.43). A significant correlation was found between BPND and Bmax/KDapp in the MTC (p=0.018).
Conclusions Our results from six subjects show that for MEF BPND is not a proxy of Bmax or KDapp, but a combination of the two (Bmax/KDapp), indicating each index provides a unique measure of ligand-receptor binding.